Business Context and Reporting Period
This Form 8-K filing by Nexalin Technology, Inc. (NXL) is dated August 14, 2026. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market. The report addresses a critical compliance issue regarding the Company's continued listing status on Nasdaq.
Key Financial Metrics
The filing references specific financial data from the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2026:
- Stockholders' Equity: $1,519,423
- Nasdaq Minimum Stockholders' Equity Requirement: $2,500,000
- Nasdaq Initial Listing Stockholders' Equity Requirement: $5,000,000
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity beyond the stockholders' equity figure.
Material Changes and Compliance Issues
The Company has received notification of two distinct deficiencies preventing continued listing on The Nasdaq Capital Market:
- Stockholders' Equity Deficiency: The Company's reported equity of $1,519,423 falls below the $2,500,000 minimum required under Nasdaq Listing Rule 5550(b)(1). The Company also fails to meet alternative continued listing standards.
- Minimum Bid Price Deficiency: Previously disclosed on July 24, 2026, the Company failed to regain compliance with the minimum bid price requirement. It is ineligible for an additional compliance period because it does not meet the $5,000,000 initial listing equity requirement.
Outlook, Risks, and Management Commentary
The Company has requested a hearing before a Nasdaq Hearing Panel, scheduled for September 1, 2026, to appeal the Bid Price Deficiency. The Panel will consider both the Bid Price Deficiency and the new Stockholders' Equity Deficiency in its determination.
Risks and Contingencies:
- There is no assurance the appeal will be successful or that an additional compliance period will be granted.
- The Panel has broad discretion to delist the Company based on factors including reverse stock split history, financial condition, and capital-raising activities.
- Delisting would have a material adverse effect on the liquidity and market price of the Company's common stock and its ability to raise capital.
Key Facts for Investor Verification
- Verify the outcome of the Nasdaq Hearing Panel scheduled for September 1, 2026.
- Confirm whether the Company can raise sufficient capital to meet the $2,500,000 stockholders' equity requirement or the $5,000,000 initial listing requirement.
- Monitor the Company's stock price to determine if it can regain compliance with the minimum bid price requirement.
- Review the Company's history of reverse stock splits, as this is a specific factor the Panel may consider for delisting.